SEC Form 4 · accession 0001203311-16-000080
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 5, 2016 | M | 7,618 | $4.45 | A | 563,733 | D | |
| Common StockF2,F3 | Apr 5, 2016 | S | 7,618 | $36.12 | D | 556,115 | D | |
| Common Stock | holding | — | — | — | 27,945 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $4.45 | Apr 5, 2016 | M | 7,618 | D | — | Sep 5, 2016 | Common Stock | 7,618 | 38,083 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- F3Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F4Shares vested at a rate of 25% on 9/06/07 and monthly thereafter until all the shares were fully vested on 9/06/10.